Skip to main content

Genprex, Inc.

Calidad de datos: 83%
GNPX
Nasdaq Manufacturing Chemicals
$1.30
▼ $0.01 (-0.76%)
Cap. Mercado: 11.76 M
Precio
$1.30
Cap. Mercado
11.76 M
Rango del Día
$1.27 — $1.36
Rango de 52 Semanas
$1.26 — $55.00
Volumen
347,675
Apertura $1.29
Promedio 50D / 200D
$2.04
36.42% below
Promedio 50D / 200D
$6.88
81.10% below

Quick Summary

Puntos Clave

Negative free cash flow of -15.31 M

Crecimiento

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Calidad

Return on Equity
-1503.38%
Below sector avg (-51.02%)
ROIC-1020.59%
Net MarginN/A
Op. MarginN/A

Seguridad

Debt / Equity
N/A
Current Ratio0.67
Interest CoverageN/A

Valoración

PE (TTM)
-0.72
Above sector avg (-1.98)
P/B Ratio15.31
EV/EBITDAN/A
Dividend YieldN/A

Historial de Precios

Tendencias Financieras

Comparación con Pares

vs mediana del sector Manufacturing (44 pares)
Métrica Acción Mediana del Sector
P/E -0.7 -2.0
P/B 15.3 5.1
ROE % -1503.4 -51.0
Net Margin % -150.2
Rev Growth 5Y % 9.3
D/E 0.3

All Fundamental Metrics

Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -16.23 M
ROE -1503.38% ROA -439.21%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -15.31 M
ROIC -1020.59% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0.67
Interest Coverage N/A Asset Turnover N/A
Working Capital -836,605 Tangible Book Value 767,807
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0.72 Forward P/E N/A
P/B Ratio 15.31 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -130.22%
Market Cap 11.76 M Enterprise Value 10.65 M
Per Share
EPS (Diluted TTM) N/A Revenue / Share N/A
FCF / Share -1.69 OCF / Share -1.69
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 94.35%
SBC-Adj. FCF -15.92 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 0.0 0.0 0.0 0.0
Net Income -16.23 M -21.11 M -30.86 M -23.74 M -19.60 M
EPS (Diluted)
Gross Profit
Operating Income -15.52 M -21.17 M -31.08 M -23.83 M -19.60 M
EBITDA
R&D Expenses 9.43 M 10.54 M 17.62 M 11.51 M 8.61 M
SG&A Expenses
D&A
Interest Expense
Income Tax 0.0 2,650.0 0.0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 10.16 M 4.12 M 10.67 M 25.09 M 42.86 M
Total Liabilities 2.20 M 2.46 M
Shareholders' Equity 7.96 M 1.62 M 7.42 M 22.27 M 41.28 M
Total Debt
Cash & Equivalents 7.83 M 1.60 M 6.74 M
Current Assets 8.36 M 2.08 M 7.53 M 21.47 M 39.14 M
Current Liabilities 2.17 M 2.50 M 3.25 M 2.81 M 1.59 M